openPR Logo
Press release

Download Global Controlled Drug Delivery Market and Clinical Trial Outlook 2022 Report

09-14-2017 08:22 AM CET | Health & Medicine

Press release from: Kuick Resarch

Download Global Controlled Drug Delivery Market and Clinical

“Global Controlled Drug Delivery Market and Clinical Trial Outlook 2022” report gives comprehensive clinical and non-clinical insight on the emergence and integration of controlled release technology in the drug delivery. Report highlights the ongoing development of more than 300 controlled release drugs in clinical trials and helps to analyze the existing clinical mechanism of 133 commercially available controlled release drugs in the market. The fundamentals and application of controlled release drug delivery encapsulated in the report helps to identify the various aspect of the growing controlled release drug delivery market.

“Global Controlled Drug Delivery Market and Clinical Trial Outlook 2022” report highlights:

Evolution and Fundamentals of Controlled Drug Delivery
Mode of Action and Approaches of Controlled Drug Delivery
Global Controlled Release Drug Market Overview
Insight on Global Controlled Release Drug Clinical Pipeline
Clinical Insight on 303 Controlled Release Drug in Clinical Trials
Clinical, Patent and Technology insight of 133 Marketed Controlled Release Drugs
Controlled Release Drug Market Future Outlook

The pharmaceutical industry is on the edge of presenting a new generation of drugs and drug delivery systems that will have a major impact on health. There is a need for innovation and diverse solutions and that suggests a great need for diverse suppliers who can bring creativity and new perspectives to the research field and the pharmaceutical industry. Access to controlled drug delivery systems and devices can have a significant impact for drug manufacturers.

Controlled drug delivery technology is the one of the most rapidly advancing area in human healthcare management and already had an enormous impact on medical technology with the potential to improve health. As the goal of any drug delivery system is to provide a therapeutic amount of drug to a proper site in the body so that the desired drug concentration can be achieved promptly and then maintained, all these characteristics are provided by controlled drug delivery technologies.

It has been observed that the controlled drug delivery system offers a sustained drug action at a predetermined rate. The drug level in the body is maintained at a constant level in this system of delivery which leads to a reduction in the undesirable side effects. The controlled drug delivery system leads to localized drug action by the spatial placement of a controlled release system which is adjacent to or in the diseased tissue itself. This system offers a targeted treatment with the use of carriers or chemical derivatives in order to deliver drug to a particular target cell type. Also, the controlled drug delivery mechanism provides for a drug release system which is based on physiology or therapeutics. This implies that the amount of drugs released and the rate at which these drugs are released are highly dependent on the physiological or therapeutic demands of the body. This leads to the maintenance of safe and effective levels of blood in the body for duration which is taken by the system to deliver the drug.

The upcoming future potential for the controlled drug delivery will be outraging the conventional forms. In the future there will be several opportunities as developments are being made in order to provide the controlled drug delivery systems. With the advent of new technologies there will be a time when science would be providing the ideal drug delivery in a controlled manner. The all unmet needs of patients, physicians and payers are being promised for better treatments, controlled delivery systems with improved therapeutic profiles, increased patient compliance and enhanced bioavailability will be making the future bright for the controlled delivery products which would be able to provide successful treatment towards several diseases.

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink: https://www.kuickresearch.com/report-global-controlled-drug-delivery-market-and-clinical-trial-outlook-2022.php

1 Drug Delivery: An Advancing Trajectory
1.1 Preface Towards Drug Delivery
1.2 Idealism of Drug Delivery System

2. Introduction to Controlled Drug Delivery
2.1 Novel Drug Delivery Systems
2.2 Preamble to Controlled Drug Delivery

3. Evolution of Controlled Drug Delivery
3.1 First Generation
3.2 Second Generation

4. Fundamentals of Controlled Drug Delivery
4.1 Prerequisites of Controlled Delivery
4.2 Rationale for Controlled Drug Delivery

5. Mechanism of Controlled Drug Release
5.1 Diffusion Controlled
5.2 Dissolution Controlled System
5.3 Water Penetration Controlled System
5.4 Erosion Controlled System
5.5 Ion-Exchange Controlled System

6. Cataloging of Controlled Drug Delivery
6.1 Classification Based Over Delivery Systems
6.2 Classification Based Over Technicality
6.3 Classification Based Over Routes

7. Approaches for Controlled Drug Delivery
7.1 Polymers
7.2 Chronopharmaceutics
7.3 Nanoparticulate Delivery System

8. Global Controlled Release Drug Clinical Pipeline Overview
8.1 Phase
8.2 Country/Region
8.3 Mode of Action
8.4 Drug class
8.5 Indication

9. Application of Controlled Drug Delivery
9.1 Diabetes
9.2 Cancer
9.3 Cardiovascular Diseases
9.4 Neurological Disorders
9.5 Infections

10. Drug Designing for Controlled Delivery
10.1 Enteral Dosage Formulations
10.1.1 Solid Dosage Forms
10.1.2 Liquid Dosage Forms
10.1.3 Inhalation Dosage Forms
10.2 Parenteral Dosage Forms
10.2.1 Injectable Dosage Forms
10.2.2 Implantable Device
10.3 General Mechanisms of Drug Release

11. Market Inclinations
11.1 Market over Routes of Administration
11.2 Market over Approaches

12. Global Controlled Drug Delivery Market Dynamics
12.1 Accelerative Parameters
12.2 Challenges

13. Global Controlled Drug Delivery Market Future Outlook
13.1 Ongoing Clinical Trials
13.2 Future Market Opportunities

14. Global Controlled Drug Delivery Clinical Trials by Company, Indication and Phase
14.1 Unknown
14.2 Research
14.3 Preclinical
14.4 Clinical
14.5 Phase-I
14.6 Phase-I/II
14.7 Phase-II
14.8 Phase-II/III
14.9 Phase-III
14.10 Preregistration
14.11 Registered

15. Marketed Controlled Release Clinical Insight by Company, Indication and Phase

16. Competitive Landscape
16.1 Allergan
16.2 Amylin Pharmaceuticals
16.3 AstraZeneca
16.4 BioAlliance Pharma
16.5 Biogen
16.6 Collegium Pharmaceutical
16.7 Controlled Therapeutics (Ferring Pharmaceuticals)
16.8 Cosmo Pharmaceuticals
16.9 Egalet
16.10 Elan Corporation
16.11 Encore Therapeutics
16.12 Flamel Technologies
16.13 GlaxoSmithKline
16.14 Heron Therapeutics
16.15 iCeutica
16.16 Mithra Pharmaceuticals
16.17 Neurim Pharmaceuticals
16.18 Novartis
16.19 Orexigen Therapeutics
16.20 Otsuka Pharmaceutical
16.21 Pfizer
16.22 Purdue Pharma
16.23 Syntex Pharmaceuticals International
16.24 Takeda
16.25 Zealand Pharma

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Kuick Research
New Delhi - 110001
India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Download Global Controlled Drug Delivery Market and Clinical Trial Outlook 2022 Report here

News-ID: 715668 • Views:

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Controlled

Controlled Atmosphere Storage Using a DataTaker
DT80 Provides Single Solution & Saves Money A company contacted CAS DataLoggers with a controlled atmosphere storage environment project as part of pilot testing for a new process. To reduce costs, existing equipment was used wherever possible. The hostile atmosphere produced was found to be incompatible with available humidity sensor technologies, requiring these measurements to be derived in real time using measurements from secondary sensors. The price of logging different sensors
Temperature Controlled Packaging Systems Market
This report presents the worldwide Temperature Controlled Packaging Systems market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-temperature-controlled-packaging-systems-2025-971 The Temperature Controlled
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Sensor Controlled Vehicle Market 2017-2022
This report splits Sensor Controlled Vehicle By Recommended Age, By Price, By Cruise Speed, By Output Power, By Rated Voltage. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside
Controlled Drug Delivery Market Controlled Drug Delivery Clinical Pipeline Repor …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1 Drug Delivery: An Advancing Trajectory 1.1 Preface Towards Drug Delivery 1.2 Idealism of Drug Delivery System 2. Introduction to Controlled Drug Delivery 2.1 Novel Drug Delivery Systems 2.2 Preamble to Controlled Drug Delivery 3. Evolution of Controlled Drug Delivery 3.1 First Generation 3.2 Second Generation 4. Fundamentals of Controlled Drug Delivery 4.1 Prerequisites
Global Controlled Drug Delivery Market & Controlled Drug Delivery Clinical Trial …
With significant paradigm shifts in drug discovery and development, the industry is also gearing up to adopt alternative drug delivery strategies in order to further facilitate drug development. Opportunities have significantly increased in the last few years. Pharmaceutical companies are collaborating with drug delivery firms to effectively target patient concerns. Many different drug delivery systems have been designed and evaluated, and a large number of strategies for site-specific drug targeting